Sam-A-Pharm Co Ltd
009300
Company Profile
Business description
Sam-A-Pharm Co Ltd is a South Korea-based company that engages in the manufacturing and selling of pharmaceuticals. The group manufactures respiratory system, antibiotics, skin system, digestive system, antipyretics, analgesics, anti-inflammatory drugs, circulatory endocrine system, general medicines, and health functional foods, and main products include Citus, Codenal, Hebron, Setofen, Tantum, Neocetin, Beforin, Geod-ak, Atok, Ridomex, and Normachu tablets.
Contact
49 Donghwa Industrial Complex-ro
Munmak-eup
Gangwon-do
Wonju-si
KORT: +82 220567200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
314
Stocks News & Analysis
stocks
Unwarranted drop in ASX share
Jittery investors misinterpret an audit for an existential crisis.
stocks
After earnings, is Disney stock a buy, a sell, or fairly valued? -
Following the highly anticipated announcement of a new CEO, here’s what we think of Disney.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,281.80 | 97.30 | 1.06% |
| CAC 40 | 8,320.41 | 7.47 | -0.09% |
| DAX 40 | 24,912.11 | 75.74 | -0.30% |
| Dow JONES (US) | 50,135.87 | 20.20 | 0.04% |
| FTSE 100 | 10,431.33 | 77.49 | 0.75% |
| HKSE | 27,266.38 | 83.23 | 0.31% |
| NASDAQ | 23,102.47 | 71.26 | 0.31% |
| Nikkei 225 | 57,699.09 | 1,335.15 | 2.37% |
| NZX 50 Index | 13,507.28 | 60.91 | 0.45% |
| S&P 500 | 6,964.82 | 32.52 | 0.47% |
| S&P/ASX 200 | 9,014.80 | 98.80 | 1.11% |
| SSE Composite Index | 4,131.98 | 3.61 | 0.09% |